Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005290 · ClinicalTrials.gov registry record · Phase 2
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure
A Phase 2 study, sponsored by Ferrer Internacional S.A..
- Terminated
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT01005290 is a Phase 2 study that was terminated before completion, run by Ferrer Internacional S.A.. The registered enrollment target is 38 participants.
The verdict
NCT01005290, a Phase 2 study, was terminated before completion, sponsored by Ferrer Internacional S.A..
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect on systolic pressure of the 3 drugs given together in the cardiovascular combination pill (acetylsalicylic acid, simvastatin, and ramipril) to the effect on systolic pressure of ramipril given alone.
Interventions
- DRUG Ramipril
- DRUG Combination pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01005290
The ClinicalTrials.gov registry entry for NCT01005290 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferrer Internacional S.A., which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ramipril is the first listed.
NCT01005290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01005290 about?
NCT01005290 is a clinical study titled "A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure". The purpose of this study is to compare the effect on systolic pressure of the 3 drugs given together in the cardiovascular combination pill (acetylsalicylic acid, simvastatin, and ramipril) to the effect on systolic pressure of ramipril given alone.
What is the current status of trial NCT01005290?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2009-10. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01005290?
The interventions under investigation include: Ramipril (DRUG), Combination pill (DRUG).
Who is sponsoring clinical trial NCT01005290?
This trial is sponsored by Ferrer Internacional S.A., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.